120 related articles for article (PubMed ID: 2026596)
1. The pathway mediating insulin's effects on pyruvate dehydrogenase bypasses the insulin receptor tyrosine kinase.
Gottschalk WK
J Biol Chem; 1991 May; 266(14):8814-9. PubMed ID: 2026596
[TBL] [Abstract][Full Text] [Related]
2. A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis.
McClain DA; Maegawa H; Lee J; Dull TJ; Ulrich A; Olefsky JM
J Biol Chem; 1987 Oct; 262(30):14663-71. PubMed ID: 3312193
[TBL] [Abstract][Full Text] [Related]
3. Genistein differentially inhibits postreceptor effects of insulin in rat adipocytes without inhibiting the insulin receptor kinase.
Abler A; Smith JA; Randazzo PA; Rothenberg PL; Jarett L
J Biol Chem; 1992 Feb; 267(6):3946-51. PubMed ID: 1310987
[TBL] [Abstract][Full Text] [Related]
4. Insulin signal transduction by a mutant human insulin receptor lacking the NPEY sequence. Evidence for an alternate mitogenic signaling pathway that is independent of Shc phosphorylation.
Berhanu P; Anderson C; Hickman M; Ciaraldi TP
J Biol Chem; 1997 Sep; 272(36):22884-90. PubMed ID: 9278451
[TBL] [Abstract][Full Text] [Related]
5. Enhanced insulin-induced mitogenesis and mitogen-activated protein kinase activities in mutant insulin receptors with substitution of two COOH-terminal tyrosine autophosphorylation sites by phenylalanine.
Ando A; Momomura K; Tobe K; Yamamoto-Honda R; Sakura H; Tamori Y; Kaburagi Y; Koshio O; Akanuma Y; Yazaki Y
J Biol Chem; 1992 Jun; 267(18):12788-96. PubMed ID: 1618780
[TBL] [Abstract][Full Text] [Related]
6. Signal transduction pathways from insulin receptors to Ras. Analysis by mutant insulin receptors.
Yonezawa K; Ando A; Kaburagi Y; Yamamoto-Honda R; Kitamura T; Hara K; Nakafuku M; Okabayashi Y; Kadowaki T; Kaziro Y
J Biol Chem; 1994 Feb; 269(6):4634-40. PubMed ID: 7508445
[TBL] [Abstract][Full Text] [Related]
7. Two naturally occurring insulin receptor tyrosine kinase domain mutants provide evidence that phosphoinositide 3-kinase activation alone is not sufficient for the mediation of insulin's metabolic and mitogenic effects.
Krook A; Whitehead JP; Dobson SP; Griffiths MR; Ouwens M; Baker C; Hayward AC; Sen SK; Maassen JA; Siddle K; Tavaré JM; O'Rahilly S
J Biol Chem; 1997 Nov; 272(48):30208-14. PubMed ID: 9374504
[TBL] [Abstract][Full Text] [Related]
8. Insulin receptors with defective tyrosine kinase inhibit normal receptor function at the level of substrate phosphorylation.
Maegawa H; Olefsky JM; Thies S; Boyd D; Ullrich A; McClain DA
J Biol Chem; 1988 Sep; 263(25):12629-37. PubMed ID: 2970462
[TBL] [Abstract][Full Text] [Related]
9. Intracellular signaling by a mutant human insulin receptor lacking the carboxyl-terminal tyrosine autophosphorylation sites.
Takata Y; Webster NJ; Olefsky JM
J Biol Chem; 1992 May; 267(13):9065-70. PubMed ID: 1577744
[TBL] [Abstract][Full Text] [Related]
10. Mutated insulin receptor Val996 reduces insulin-dependent generation of inositol glycan and diacylglycerol.
Suzuki S; Taneda Y; Hirai S; Yamamoto-Honda R; Toyota T
Diabetes; 1992 Nov; 41(11):1373-9. PubMed ID: 1327926
[TBL] [Abstract][Full Text] [Related]
11. Two sequences flanking the major autophosphorylation site of the insulin receptor are essential for tyrosine kinase activation.
Leconte I; Clauser E
Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):465-72. PubMed ID: 7887900
[TBL] [Abstract][Full Text] [Related]
12. Hybrid formation between endogenous mouse and transfected human tyrosine kinase-deficient (A/K1018) insulin receptors leads to decreased insulin sensitivity in 3T3-L1 adipocytes.
Grako KA; McClain DA; Olefsky JM
Mol Endocrinol; 1994 Jun; 8(6):682-92. PubMed ID: 7935484
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine kinase-defective insulin receptors undergo decreased endocytosis but do not affect internalization of normal endogenous insulin receptors.
Grako KA; Olefsky JM; McClain DA
Endocrinology; 1992 Jun; 130(6):3441-52. PubMed ID: 1317784
[TBL] [Abstract][Full Text] [Related]
14. Properties of a human insulin receptor with a COOH-terminal truncation. II. Truncated receptors have normal kinase activity but are defective in signaling metabolic effects.
Maegawa H; McClain DA; Freidenberg G; Olefsky JM; Napier M; Lipari T; Dull TJ; Lee J; Ullrich A
J Biol Chem; 1988 Jun; 263(18):8912-7. PubMed ID: 2837468
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of impaired metabolic signaling by a truncated human insulin receptor. Decreased activation of protein phosphatase 1 by insulin.
Begum N; Olefsky JM; Draznin B
J Biol Chem; 1993 Apr; 268(11):7917-22. PubMed ID: 8385127
[TBL] [Abstract][Full Text] [Related]
16. A peptide-based protein-tyrosine phosphatase inhibitor specifically enhances insulin receptor function in intact cells.
Kole HK; Garant MJ; Kole S; Bernier M
J Biol Chem; 1996 Jun; 271(24):14302-7. PubMed ID: 8662948
[TBL] [Abstract][Full Text] [Related]
17. Dissection of the growth versus metabolic effects of insulin and insulin-like growth factor-I in transfected cells expressing kinase-defective human insulin receptors.
McClain DA; Maegawa H; Thies RS; Olefsky JM
J Biol Chem; 1990 Jan; 265(3):1678-82. PubMed ID: 2153140
[TBL] [Abstract][Full Text] [Related]
18. The insulinomimetic agents H2O2 and vanadate stimulate tyrosine phosphorylation of potential target proteins for the insulin receptor kinase in intact cells.
Heffetz D; Rutter WJ; Zick Y
Biochem J; 1992 Dec; 288 ( Pt 2)(Pt 2):631-5. PubMed ID: 1281409
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of enhanced transmembrane signaling by an insulin receptor lacking a cytoplasmic beta-subunit domain.
Sasaoka T; Langlois WJ; Rose DW; Olefsky JM
J Biol Chem; 1995 May; 270(18):10885-92. PubMed ID: 7738028
[TBL] [Abstract][Full Text] [Related]
20. Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin.
Chou CK; Dull TJ; Russell DS; Gherzi R; Lebwohl D; Ullrich A; Rosen OM
J Biol Chem; 1987 Feb; 262(4):1842-7. PubMed ID: 3100537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
